Akanda

Akanda Days Payable Outstanding

The Days Payable Outstanding (DPO) of Akanda (AKAN) as of Oct 26, 2026 is 2,916.70. In the previous year, Days Payable Outstanding (DPO) was 1,590.39 — a change of 83.40% (higher).

Days Payable Outstanding

2,916.70

YoY

83.40%

Last updated:

Days Payable Outstanding (DPO) of Akanda is 2025 2,916.70 . Days Payable Outstanding (DPO) of Akanda was 2024 1,590.39 . It decreases by 83.40% higher compared to the previous year.

The Akanda Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2020
37,104.30 USD
Jan 1, 2021
328.40 USD
Jan 1, 2022
4,010.04 USD
Jan 1, 2023
1,071.62 USD
Jan 1, 2024
1,590.39 USD
Jan 1, 2025
2,916.70 USD
The Akanda Days Payable Outstanding history
YEARDays Payable OutstandingYoY
2,916.70+83.40%
1,590.39+48.41%
1,071.62-73.28%
4,010.04+1,121.10%
328.40-99.11%
37,104.30—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Akanda Stock analysis

What does Akanda do? Akanda Corp generates revenue through its cultivation, distribution, and corporate segments. The cultivation segment focuses on producing medical cannabis and biomass, while the distribution segment sells products like those from Holigen, a Portugal-based cultivator, manufacturer, and distributor, and CanMart, a UK-based pharmaceutical importer and distributor supplying pharmacies and clinics. Holigen operates a 20,000 square foot indoor facility near Lisbon for high-THC cannabis cultivation. The company’s supply chain includes Cansativa Group, an European medical cannabis importer and distributor, and Cellen Life Sciences Leva Clinic, a UK-based digital pain clinic. Holigen’s products are distributed through Akanda’s network, targeting medical cannabis patients globally. CanMart serves UK pharmacies and clinics, leveraging its pharmaceutical licensing. Cansativa Group and Cellen Life Sciences Leva Clinic are integral to the seed-to-patient supply chain, connecting cultivation with end users. The company monetizes its portfolio by supplying ethically sourced medical cannabis products to patients worldwide through these established brands. Akanda’s revenue streams are derived from the sale of medical cannabis products via Holigen’s cultivation, CanMart’s distribution, and the supply chain involving Cansativa Group and Cellen Life Sciences Leva Clinic. The cultivation segment produces biomass for distribution, while the distribution segment handles sales to healthcare providers and clinics. The corporate segment supports these operations with strategic oversight. Akanda is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Akanda stock

Days Payable Outstanding (DPO) of Akanda is 2,916.70 in 2025.

Days Payable Outstanding (DPO) of Akanda changed from 1,590.39 to 2,916.70, representing a 83.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Akanda since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Akanda with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Akanda

All Key Metrics — Akanda